The current article is a review of the most important, accessible and relevant literature published between April 2020 and March 2021 on the gut microbiota and inflammatory bowel disease (IBD) treatments. The major areas of publication during this period were human studies involving probiotic supplementation and fecal microbiota transplantation including mechanistic insights from animal models as well as papers covering the more traditional pharmacological IBD treatments.